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Abstract
Novel, porous, biodegradable biomaterials which support tissue integration and angiogenesis 
and which have elastomeric properties are needed to repair and replace soft tissues in dynamic 
environments. In this study poly(glycerol sebacate urethane) (PGSU) scaffolds with different  
porous structures were fabricated using freeze-drying by varying the polymer concentration of 
the freeze-drying solution, during which the polymer was further crosslinked. The effect of the 
porous structure on the physical properties, cell proliferation, tissue ingrowth and angiogenic 
properties was investigated. By increasing the polymer concentration in the freeze-drying 
solution from 5 w/v% to 10 w/v% and 15 w/v%, the porosity and pore size of the scaffold 
decreased, resulting in porosities ranging between 88 – 96% and pore sizes 6.4 – 28.2 μm. The 
mechanical properties increased with the polymer concentration, with ultimate tensile strength 
and Young’s modulus between 0.05 – 0.86 MPa and 0.05 – 0.65 MPa respectively and 
negligible loss of tensile strength after 100 cycles of loading. Enzymatic degradation over 28 
days demonstrated linear degradation kinetics with mass loss between 19.1 – 52.3%. All PGSU 
scaffolds provided a viable environment for cell attachment, in which cell metabolic activity 
increased over time indicating cell proliferation. The cells adhered to PGSU scaffolds produced 
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and deposited high quantities of collagen, reaching 7.5% of the sample’s dry mass after 14 days 
culture for the scaffold with the highest porosity. Additionally, the scaffolds with the polymer 
concentration of 5 w/v% implanted onto the chick chorioallantoic membrane supported rapid 
tissue ingrowth and new blood vessel formation within the porous scaffold. These results 
demonstrate that PGSU scaffolds have potential for use in many areas of soft tissue 
engineering.
Keywords
Poly(glycerol sebacate urethane); Freeze-drying; Tissue scaffold, Collagen production; 
Angiogenesis; Soft tissue engineering
1. Introduction
Tissue engineering (TE) is a multidisciplinary field, aiming to regenerate or replace damaged 
and malfunctioned tissues or organs [1]. The success of tissue engineered products relies on 
developing scaffolds which support cell survival and integration into host tissues. Scaffolds 
with high porosity and highly interconnected pore structures are desirable as they mimic 
naturally occurring tissue structures, allow cell-cell communication as well as facilitating gas 
and nutrient exchange for cell proliferation [2]. Following implantation, the degradation of 
scaffolds and simultaneous substitution with cell derived matrix proteins enable long term 
tissue replacement [3]. Therefore the development of new biomaterials which are 
biocompatible, biodegradable and can be fabricated into 3D structures with defined porous 
structure and mechanical properties are needed [4]. Furthermore, ensuring new blood vessels 
populate scaffolds rapidly after implantation, in order for cells to receive an adequate supply 
of gas and nutrients, remains a great challenge in TE [5].
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The most common synthetic biodegradable biomaterials developed for TE scaffolds are 
poly(lactic acid) [6], poly(lactic-co-glycolic acid) (PLGA) [7], poly(ε-caprolactone) (PCL) [8] 
and poly(ethylene glycol) (PEG) [9]. One of the shortcomings of these polymers are that their 
mechanical properties do not match the elastic properties of extracellular matrix in many soft 
tissues, and they undergo plastic deformation and fail when exposed to cyclic loading [10]. To 
overcome these disadvantages, poly(glycerol sebacate) (PGS) was developed which is a 
biocompatible and biodegradable elastomer synthesised by polycondensation of glycerol and 
sebacic acid [11]. PGS is capable of sustaining a load and recovering from mechanical 
deformation allowing it to be used for soft tissues that are in dynamic environments [12]. In 
addition, its mechanical properties and degradation rate can be tailored by controlling the 
molecular weight of the PGS prepolymer (pre-PGS) and curing conditions, supporting its 
development as a biomaterial for soft TE applications [13, 14]. In previous studies, PGS was 
reported to have an ultimate tensile strength (UTS) between 0.23 – 0.79 MPa, Young’s 
modulus (E) 0.04 – 2.12 MPa and elongation at break (εb) 69 – 448%  [11, 14, 15]. In vivo 
studies have demonstrated that PGS degrades fully between 35 and 60 days by surface erosion. 
During degradation, PGS loses only ~8% of its mechanical strength every week [13, 16], and 
its Young’s modulus decreases by only 50% even after ~70% degradation, which is an 
important characteristic many other polymeric biomaterials fail to achieve [16]. The 
disadvantage of PGS is that it requires high curing temperatures (~140 oC), long curing time 
(days) and high vacuum pressure, which limits the ability to fabricate a 3D porous scaffold 
[15]. Researchers have addressed this issue by chemically modifying the PGS synthesis (e.g. 
adding reactive acrylate moieties to produce poly(glycerol sebacate) acrylate, making it UV 
curable [17]) or using a second material to support the structure while curing (e.g. poly(glycerol 
sebacate)/poly(L-lactic acid) [11, 15]).
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Recently Pereira et al. [18] introduced hexamethylene diisocyanate (HDI) that reacted with 
the hydroxyl groups of PGS to form a chemically crosslinked poly(glycerol sebacate urethane) 
(PGSU).  This method has the advantage of using mild temperature (55 oC) for a short period 
(5 h) to crosslink the material followed by solvent removal. PGSU films were characterised 
and have been shown to be biocompatible, with a wide range of mechanical properties and 
tuneable degradation rate depending on the synthesis method and the amount of crosslinker 
[18]. In the previous work from our group, Frydrych and Chen [19] prepared large 3D PGSU 
scaffolds using freeze-drying, synthesised with three different HDI contents. Using this 
technique, a PGSU prepolymer solution was frozen at -30 oC and the solvent (1,4-dioxane) was 
sublimed directly from solid phase into vapour phase at -5 oC by reducing the chamber 
pressure, leaving a porous PGSU prepolymer scaffold followed by curing (at 37 oC for 48 
hours) to obtain large 3D PGSU scaffolds [19, 20]. The effects that the crosslinker content has 
on the porous structure and physical properties of scaffolds were investigated. By increasing 
the crosslinker content, the porosity, pore size, tensile strength and elongation at break of the 
scaffold increased while the degradation rate reduced [19]. The scaffolds showed 
similar mechanical properties to those of human cardiac muscle and adipose tissue [19]. 
Another study from Frydrych et al. [21] fabricated PEGylated PGSU (PEU) bioelastomers 
and characterised their physical and biological properties in both dry and hydrated 
states. The mechanical properties, biodegradation rate and water swelling amount of the 
polymer can be modulated by varying the molecular weight of PEG [21]. Subsequently, 
Wang et al. [22] also synthesised PEU bioelastomer films and by varying the PEG and HDI 
contents the elastomers exhibited a large range of mechanical properties, degradation rate 
and water contact angle. The PEU elastomers demonstrated favourable biocompatibility in 
vitro and mild host response in vivo [21, 22]. Another method of varying a scaffold’s 
properties is to alter porous structure directly without changing the chemical structure of the 
polymer. A suitable porous structure  is essential 
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in a scaffold, as it is necessary for cell seeding and vascular ingrowth [23]. For 
example, polyurethane scaffolds were fabricated with two different porosities, 73% and 86%, 
and were subcutaneously implanted on the back of 24 Winstar albino rats and examined 
for tissue ingrowth after 24 weeks. Significantly higher tissue ingrowth was found for the 
86% porosity scaffolds [24]. A higher degree of porosity decreases stiffness and strength, 
but allows for bodily fluids to perfuse the structure more easily, and allows for more rapid 
ingrowth of host tissue [25]. 
Freeze drying is a scaffold fabrication technique, where a material is dissolved into a solvent 
which is frozen and removed by sublimation as mentioned above. It has the advantage of not 
using a high temperature compared to melt-based fabrication techniques (e.g., compression 
moulding, extrusion and injection moulding) which could have drawbacks such as denaturation 
of the polymer [26]. Furthermore, it does not require a separate leaching step as opposed to 
particular leaching which could result in particle residue that could affect the biocompatibility 
of the scaffold. Additionally, the freeze-drying technique enables control of pore size and 
porosity based on the freeze-drying procedure and freezing solution (e.g. polymer 
concentration) [20]. 
In this study freeze-drying was used to fabricate PGSU scaffolds with different pore sizes 
and porosities by varying the polymer concentration, aiming to determine their effect on the 
mechanical properties and degradation of the scaffold as well as the biological response to the 
scaffolds in vitro and in vivo. The microstructure of the scaffolds was determined by scanning 
electron microscopy (SEM), the mechanical properties were investigated by quasi-static, cyclic 
tensile testing and suture retention strength measurement, and the degradation rate was 
monitored in vitro using an enzyme that is relevant to the in vivo environment. The in vitro cell 
activity was studied using resazurin assay and Sirius red over 15 days of culture (measuring 
cell viability and matrix production), and the in vivo biological response was assessed using a 
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chick embryo model to study tissue response and angiogenesis. The chick chorioallantoic 
membrane (CAM) assay is a functional angiogenesis assay which is used to measure the effect 
biomaterials have on angiogenesis, tissue ingrowth and tissue response ex ovo [27]. The new 
knowledge gained from this study will inform the development of PGSU scaffolds for a range 
of soft TE applications.
2. Materials and Methods
2.1. Materials
Sebacic acid (99%), glycerol (>99%), 1,4-dioxane (anhydrous, 99.8%), hexamethylene 
diisocyanate (99%), Tin(II) 2-ethylexanoate, lipase enzyme from porcine pancreas (54 U mg-
1), Dulbecco’s modified eagle’s medium (DMEM), penicillin-streptomycin (P/S), L-glutamine 
(200 mM), fetal calf serum (FCS), MEM non-essential amino acid solution (NEAA), HEPES 
buffer solution (1M), trypsin–ethylenediaminetetraacetic solution (trypsin/EDTA), resazurin 
sodium salt and direct red 80 were purchased from Sigma-Aldrich. Fertilised pathogen-free 
chicken eggs were purchased from Henry Stewart & Co. Phosphate buffer saline (PBS) and L-
ascorbic acid were purchased from ThermoFisher Scientific and Mineral Water Chemical 
Supplies respectively.
2.2. Methods
2.2.1. PGSU synthesis and scaffold fabrication
The synthesis method of PGS pre-polymer was performed according to published methods [13, 
28]. Briefly, 1:1 molar ratio of sebacic acid and glycerol were reacted at 120 oC for 72 hours 
under a low nitrogen gas flow while stirring. The protocol for synthesising PGSU was adopted 
from the work of Pereira et al [18] with some modifications [19]. Pre-PGS was firstly dissolved 
into 1,4-dioxane at the required concentrations (5, 10 and 15 w/v%) mixed with 0.05 w/v% 
Tin(II) 2-ethylexanoate and pre-heated at 55 oC. HDI was then added at a 0.6 molar ratio 
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(glycerol:HDI) and left to react for 5 hours at 55 oC under constant stirring. For PGSU films 
the solution was cast in a PTFE tray and left overnight to dry and further crosslinking. For 
porous scaffolds the solution was cast into an aluminium mould and placed into a freeze 
dryer (FreeZone Triad Dry System, Labconco Co., USA) that was precooled to -50 oC and 
left for 3 h for the solution to completely freeze. The drying process then started with 
the shelf temperature heated at a rate of 1 oC/min to 0 oC and left for 16 h under vacuum 
pressure (0.1 mbar). For the secondary drying stage the temperature was increased at a rate of 
1 oC/min to 40 oC for another 48 h [19] which also allowed further crosslinking of the 
polymer. The scaffolds were then washed with 100% ethanol for 24 h to remove any 
unreacted molecules (sol content shown in Table S1, Supplementary content) and the image 
of the scaffold is shown in Figure S1, Supplementary content. For ease of documentation, 
the nomenclature of the samples is PGSU-X where X refers to the polymer concentration 
(w/v%), 5%, 10%, 15% or film.
2.2.2. Characterisation
To examine the microstructure of the porous scaffolds an FEITM Inspect F50 SEM was 
utilised. The porous samples were attached on an aluminium stub and were gold coated using 
a High Resolution Polaron Sputter Coater at 15 kV voltage for 1.5 min. To measure the average 
pore diameter (n=50) ImageJ software was used.
The porosity of the scaffolds was measured using the gravimetric method [29]. Briefly, the 
densities of porous scaffold (��) and film (��) were calculated by dividing the mass with the 
volume of the sample, measured using a four-decimal point balance and a three-decimal 
calliper respectively. Five specimens were used from each batch of scaffolds. Knowing the 
density of the sample, equation (1) was then used to calculate the porosity,
�= (1 ‒ ����) × 100 (1)
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PGSU porous scaffolds were tensile tested following the BS EN ISO 1798:2008 standard 
using a Hounsfield H100KS testing machine (Tinius Olsen, USA). The samples were prepared 
in dog-bone shape (using test sample cutter with gauge length = 25 mm, width = 3.25 mm) and 
tested at a 500 mm/min rate of travel using a 10 N load cell until failure. Sufficient test pieces 
were used to provide 5 breaks within the gauge length. Same sample dimensions (n = 3) were 
also used for cyclic loading in which the samples were tensile loaded to 30% strain for 100 
cycles at 100 mm/min rate of travel using a 10 N load cell. The first and last cycles were 
recorded and plotted as strain-stress curves.
The suture retention strength was measured according to BS EN ISO 7198:2017 standard. 
The sample was cut normal to the long axis and a suture was inserted 2 mm from the end of 
the sample and a half loop was formed. The suture was then pulled, using a 10 N load cell, at 
200 mm/min and the force required to pull the suture through was recorded and plotted in 
grams. Five specimens were tested for each condition.
In vitro degradation was performed on the PGSU scaffolds using lipase enzyme from 
porcine pancreas at an activity of 40 U/ml [19, 30]. Prior to the experiment all samples were 
sterilised with 70% ethanol overnight, and then dried in a vacuum oven overnight at 40 oC. 
The samples (20 x 5 x 10 mm) were fully submerged in triplicates into PBS/lipase solutions 
at an average mass to volume ratio of  3.2 mg/ml for a total of 28 days and placed in a 
shaker incubator at 37 oC and 100 rpm, changing the enzyme solution every day. Every 7 
days the samples were washed thoroughly with distilled water and dried in a vacuum oven 
at 25 oC overnight. The samples were then weighed, recorded, and then placed back into 
the enzyme solution. Samples were also degraded in PBS without enzymes as a control.
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2.2.3. In vitro cell culture experiments
L929 cells (immortalised mouse fibroblast cell line from ATCC, Middlesex, UK) were cultured 
using DMEM supplemented with fetal calf serum (FCS 10% (v/v)), 2 mM L-Glutamine, 1% 
NEAA, 100 IU/ml penicillin, 100 μg/ml streptomycin and 10 mM HEPES).
PGSU scaffolds were prepared with diameter = 10 mm, thickness = 2 mm in triplicates for 
each concentration. The samples were sterilised overnight with 70% ethanol and then under 
sterile environment washed thoroughly with PBS. The samples were then placed in a 12 well-
plate and fixed within a 10 mm inner diameter stainless steel ring. The samples were passively 
seeded, by overlaying them with 200 μl of cell/media suspension (1.0 x 106 cells/sample which 
amounts to ~6000 cells/mm3) and topped up to 2 ml after 2 h incubation. The next day the 
seeded scaffolds were moved to a fresh well-plate to ensure that any cell activity measured 
during the experiments was due to the cells on the scaffold. All the cell cultures were carried 
out for 15 days. Cells seeded on the tissue culture plastic (TCP) acted as positive control, and 
acellular scaffolds as negative control. 
The cell metabolic activity was measured every 3 days using resazurin metabolic activity 
assay. Resazurin working solution was prepared by dissolving 0.25% (w/v) resazurin sodium 
salt into media. The samples were washed 3 times with PBS, and 2 ml of working solution was 
added to each sample and left in the incubator for 3 h, wrapped in aluminium foil. Then, 200 μl 
were transferred into a 96 well-plate in sextuplicate, and the fluorescence was read at 540 nm 
excitation, 590 nm emission on an absorbance plate reader (Bio-Tek ELx800). The samples 
were then washed three times and fresh media was added.
After 15 days culture the samples were fixed into 3.7% formaldehyde. The samples were 
paraffin-embedded and sectioned (6 μm). The sections were dewaxed, rehydrated and stained 
with haematoxylin and eosin (H&E). Live/dead assay fluorescent staining was not used in 
this 
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case due to the high affinity of the fluorescent stain to the PGSU resulting in a significant 
background staining and hence invisible stained cells.  
The collagen production was quantified using Sirius red stain (0.1% (w/v) Direct Red 80 in 
saturated picric acid). The stain was added (2 ml per sample) and left for 16 h to bind on the 
collagen. The excess stain was then removed by washing the sample with distilled water for 15 
times. The samples were then dried in a vacuum oven at 25 oC, weighed and the stain was 
eluted using 2 ml of 0.2 M NaOH:methanol 1:1 for 15 min on a rocking shaker. The absorbance 
was then measured at 490 nm in an absorbance plate reader (Bio-Tek ELx800).
2.2.4. Studies of angiogenic properties
The CAM assay was carried out using the ex ovo method as described in [31] and complied 
with Home Office regulations. For this assay PGSU-5% and PGSU-10% scaffolds were used, 
with PGSU films acting as a control. Fertilised chicken eggs were incubated for 3 days in an 
R-Com King Suro 20 digital egg incubator at 37.8 ºC. On day 3 post fertilisation, embryos 
were removed from their shells, transferred into sterile 100 ml weighing boats with 2 ml PBS 
containing 100 IU/ml penicillin, 100 μg/ml streptomycin, placed in petri dishes containing 12 
ml distilled water to conserve humidity and incubated at 37 °C in a humidified cell culture 
incubator. On day 7 post fertilisation PGSU samples were placed onto the surface of each CAM 
and images taken of the samples with surrounding vasculature. Blood vessel growth towards 
the scaffold was imaged on days 12 post fertilisation using a Motorola USB microscope 
coupled with Microcapture imaging software. On day 13 the embryos were sacrificed and 
samples (including the attached CAM) were fixed in 3.7% formaldehyde and were processed 
for histological analysis. Quantification of vascular growth was performed on blinded samples 
as per [32]. Briefly, images were greyscaled, sharpened, despeckled, sharpened again, adjusted 
using ImageJ before the blood vessels growing perpendicularly (within ±45°) towards the 
samples were manually counted.
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2.3. Statistics
The statistical analysis was performed using one-way and two-way ANOVA with post hoc 
Tukey with null hypothesis set that there is no interaction between sample groups, using 
Graphpad Prism. All measurements were reported as mean ± standard deviation (SD), and 
considered significant when p ≤ 0.05.
3. Results
3.1. Characterisation of PGSU scaffold
3.1.1. Microstructure of the PGSU scaffolds
Porous PGSU scaffolds were observed using SEM, and they presented a relatively uniform 
open pore interconnected structure in the centre of the cross-sectional areas (Figure 1A-C). 
Figure 1D shows the measured pore size and porosity from these areas. The pore size 
significantly decreased from 28.2 ± 5.3 μm to 16.1 ± 2.6 μm, as the polymer concentration 
increased from 5% to 15% (w/v). The same observation was found for porosity, with PGSU-
5% the most porous (96.4 ± 0.3%), PGSU-15% the least porous (88.9 ± 0.4%), and PGSU-
10% in between (92.3 ± 0.7%). However, the pore structure remained similar, with stacked 
elongated pores and high uniformity. It was also found that the scaffolds exhibited different 
porous structures between their top, cross-section and bottom areas (Figure S3, Supplementary 
content), in part due to the low freezing temperature (-50 oC) and fast freezing used in this work 
(the solution was placed in the pre-cooled freeze dryer shelf for freezing). The pore sizes and 
porosities of the scaffolds at different areas are presented in Figure S4, Supplementary content. 
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Figure 1: SEM images of porous (A) PGSU-5%, (B) PGSU-10% and (C) PGSU-15% scaffolds with their 
measured (D) pore sizes and porosities. The SEM images were taken from the centre of the cross-section area of 
the scaffolds. (Results are shown mean ± standard deviation, n=50, *** when p < 0.001)
3.1.2. Mechanical Properties
The scaffolds were subjected to tensile testing to examine their mechanical behaviour. Figure 
2A shows the stress-strain curves of PGSU scaffolds fabricated with different polymer 
concentrations, and Figure 2B-D show the summary of the results. When the polymer 
concentration increased, so did the E, UTS and ε with the highest values obtained from PGSU-
15% equal to 0.65 ± 0.18 MPa, 0.86 ± 0.21 MPa and 122 ± 19 %, respectively. The polymer 
concentration significantly affected E, which increased ~9 folds between PGSU-5% and 
PGSU-10%, ~12 folds for PGSU-5% against PGSU-15% and ~1.5 folds when comparing 
PGSU-10% with PGSU-15% (Figure 2B). Similar increases were found for the UTS, when 
comparing PGSU-5% to PGSU-10% it increased by ~9 folds, PGSU-5% to PGSU-15% it 
increased ~16 folds and PGSU-10% to PGSU-15% it increased ~2 folds (Figure 2C). The 
elongation at break was only higher with statistical significance when comparing the values of 
PGSU-5% and PGSU-15% (~1.3 folds higher) (Figure 2D). A negligible loss of tensile strength 
was observed for all three scaffolds after 100 tensile cycles, signifying the ability of the scaffold 
to recover its strength and shape after deformation (Figure 2E). Another mechanical property 
that was examined was the suture retention strength of the scaffolds, shown in Figure 2F. As 
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expected the suture retention was significantly increased while the polymer concentration 
increased, with the highest force to be 247.5 ± 37.5 g, which is well above the surgical 
requirement (183 g [33], shown as dotted line).
Figure 2: (A) Representative tensile stress-strain curves, (B) Young’s modulus, (C) ultimate tensile strength, (D) 
elongation at break, (E) cyclic loading curves, and (F) suture retention strength of the PGSU scaffolds. (Results 
are shown mean ± standard deviation, n=5, * when p<0.05, ** when p<0.01 and *** when p<0.001)
3.1.3. In-vitro biodegradation
Figure 3 shows the mass loss of the scaffolds over time degraded in lipase-containing PBS 
solution, with enzyme-free PBS as a control. When the concentration of polymer was 
increased, the degradation rate decreased. In lipase PGSU-5% degraded 52.3 ± 3.8%, a slightly 
slower degradation rate was observed for PGSU-10% with mass loss equal to 39.3 ± 3.9% and 
consequently, the highest concentration, PGSU-15%, exhibited an even smaller mass loss of 
19.1 ± 1.0%. For the scaffolds degrading in the PBS without the enzyme there was only 
minimal mass losses observed (PGSU-5% = 1.99 ± 0.55%, PGSU-10% = 0.47 ± 0.23%, PGSU-
15% = 0.22 ± 0.19%) from all three scaffolds with no significant difference between the groups.
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Figure 3: In-vitro enzymatic degradation of PGSU5%, 10% and 15% scaffolds. Samples were degraded in PBS 
as a control. (Results are shown mean ± standard deviation, n=3, *** when p<0.001)
3.2. Cell culture
3.2.1. Cell activity
Scaffolds in TE must provide the cells with a viable environment in order for them to adhere 
and proliferate. To test this, the scaffolds were seeded with L929 mouse fibroblast cells, which 
are the cells specified by BS EN ISO 10993-5:2009 for biological evaluation of medical 
devices and the results are shown in Figure 4. Over 15 days culture the cell activity significantly 
increased every 3 days reaching ~4 times higher cell activity. No significant difference was 
found between polymer concentration groups and no increase was observed following day 12 
suggesting cell confluence was reached.
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Figure 4: Cell activity of L929 cells seeded on PGSU-5%, 10% and 15% scaffolds measured by resazurin assay. 
Arbitrary unit = a.u. (Results are shown mean ± standard deviation, n=3, *** when p < 0.001)
The samples were fixed and sectioned at the end of the 15 days culture and histological 
analysis was performed to observe their cross section, shown in Figure 5. Cells were attached 
onto all the three types of the scaffold, with a dense cell layer on the seeding surface (i.e., top 
surface). When comparing the cell penetration inside the scaffolds, the cells penetrated deeper 
for the PGSU-5%, and less penetration was found in the scaffold with the higher polymer 
concentrations.
Figure 5: Histological analysis (H&E staining) of the cell seeded PGSU scaffolds for all three concentrations 
(A) PGSU-5%, (B) PGSU-10% and (C) PGSU-15%.
3.2.2. Collagen content
Figure 6 shows the results of the collagen content (collagen / dry sample (w/w%)) measured 
by Sirius red on cell seeded scaffolds cultured for 15 days. The PGSU-5% showed a 
significantly higher collagen content, 7.5 ± 2.6%, compared to the PGSU-10%, 1.7 ± 0.6%, 
and PGSU-15%, 0.4 ± 0.3%. Macroscopic images of the stained PGSU samples were also 
taken and are shown in Figure S5, Supplementary content, which demonstrated difference in 
colour intensity prior to eluting the stain. SEM images were also taken looking at the cross 
section of the samples after the 15 days cell culture (Figure 6B, D). The SEM images 
demonstrated that the original, highly porous PGSU-5% scaffold had an enclosed pore 
structure due to the newly-produced collagen and other extra-cellular matrix (ECM) deposition, 
which was less visible in other polymer concentration scaffolds.
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Figure 6: (A) Collagen content as a percentage of the dry sample’s mass deposited by L929 cells after 15 days 
of culture. SEM images of (B) PGSU-5%, (C) PGSU-10% and (D) PGSU-15% from the cross section of the 
scaffolds after culture. (Results are shown mean ± standard deviation, n=3, ** when p < 0.01)
3.3. Angiogenic properties
The ability of new blood vessels to penetrate PGSU scaffolds with different surface pore sizes 
was tested with the ex ovo CAM assay. In this assay the chick membrane was in contact with 
the bottom surface of PGSU-5% and PGSU-10% scaffolds and it is expected the size of the 
pores on the bottom surface of the scaffold contributed more to our observations compared to 
the cross-sectional pore size. PGSU-5% and PGSU-10% scaffolds with surface pore sizes of 
26.5 ± 5.5 μm and 11.0 ± 2.2 μm respectively (Figure S4, Supplementary content) were 
compared to non-porous PGSU-film samples to assess the effect of pore size on angiogenesis 
and tissue ingrowth. The addition of PGSU scaffolds to the CAM did not affect the viability of 
the chick embryos used compared to control PGSU-film sample. Figure 7 shows the 
development of and changes in the chorioallantoic membrane vasculature between days 7 and 
12 following implantation with PGSU-film (A1, A2), PGSU-5% scaffold (B1, B2) and PGSU-
10% scaffold (C1, C2). Following 5 days incubation with the PGSU-scaffolds more vessels 
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were observed growing towards the scaffolds. In contrast, the chick vasculature appears to be 
unaffected by the presence of the PGSU in the PGSU-film samples, with vasculature 
developing as is observed in untreated samples. Figure 7D shows the increase in the number 
of new blood vessels growing perpendicularly towards each scaffold between days 7 and 12. 
The CAM exposed to PGSU films did not demonstrate any change in the number of vessels 
growing towards the sample, however the PGSU-5% samples showed an average increase of 
10.3 vessels while the PGSU-10% samples showed an average increase of 2.3 vessels which is 
significantly lower than the lower concentration scaffolds (PGSU-5%) but significantly higher 
than the control (PGSU-film) sample.
Figure 7: Optical micrographs of (A1, 2) PGSU-film, (B1, 2) PGSU-5% scaffold and (C1, 2) PGSU-10% scaffold 
and surrounding vasculature on CAM at 7 and 12 days post fertilisation. Yellow line shows position of vessel 
ingrowth measurements. The graph (D) shows the increase in number of blood vessels growing towards the 
samples between day 7 and 12. (Results are shown mean ± standard deviation, n=3, *** when p < 0.001)
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During histological processing the PGSU-film detached from the CAM however the 
membrane adjacent to the film samples remained well-defined (as labelled in Figure 8A, B) 
and the allantoic membrane was uniform and undisturbed. 
The PGSU-5%, shown in Figure 8C, D, had undergone complete tissue integration, with the 
allantoic epithelium being completely indistinguishable. Ingrown tissue was dense and mostly 
devoid of gaps, with some evidence of primitive blood vessel formation (indicated by arrows 
showing the round vessel like structures containing nucleated chick red blood cells). Tissue 
ingrowth was observed as deep as 0.8 mm with most pores being densely filled by cells.
The PGSU-10% scaffold (Figure 8E, F) showed very limited tissue integration, with only 
the sides of the sample exhibiting some ingrowth (where pore size is larger). Even on the sides 
of the sample, the tissue was unable to penetrate the sample to any considerable depth (0.1 
mm).
Figure 8: H&E stained histological images of (A, B) PGSU-film, (C, D) PGSU-5% and (E, F) PGSU-10% and 




For the first time large 3D PGSU scaffolds were assessed for their in vitro cell biocompatibility, 
ex ovo tissue response and angiogenesis. To perform this study, we synthesised and fabricated 
porous PGSU scaffolds with various microstructures and physical properties as both have been 
shown to affect the cell biocompatibility, tissue ingrowth and angiogenesis [24, 34].
The main findings were that the PGSU scaffolds with larger pore size and higher porosity 
(PGSU-5%) stimulated a large amount of collagen production and a rapid angiogenesis as well 
as deep tissue ingrowth during CAM assay.
The synthesis procedure of PGSU was reported before in [15, 18, 19, 35] and this study 
followed similar procedures. This study began by examining the chemical structure of PGSU 
using attenuated total reflection - Fourier transform spectroscopy (ATR-FT-IR) that confirmed 
the successful synthesis and chemical structure of PGSU, shown in Figure S2, Supplementary 
content. The results closely resembled the results of Pereira et al. [18] and Frydrych and Chen 
[19] even with the synthesis modification. Additionally, the absence of the characteristic HDI
peak (2250 cm-1) from the PGSU spectrum, demonstrated a complete reaction of the isocyanate 
groups with the hydroxyl groups.
During freeze drying the pores in the scaffold are dependent on the freezing process, as the 
ice crystals formed during freezing leave a pore in the scaffold after it has sublimed. In this 
study, we freeze dried the scaffolds using the same freeze-drying cycle, but with different 
concentrations of the polymer in the freeze-drying solution. The results demonstrate that 
altering the polymer concentration is an effective way to control pore size as well as the 
porosity of the scaffold during freeze-drying, in line with the literature [23, 36]. The porosity 
decreased significantly when polymer concentration increased, and we obtained higher 
porosity compared to previously reported PGSU scaffolds (87.9 ± 1.3%) that used a lower 
polymer concentration of 2.6% [19]. This increased porosity is thought to be due to different 
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freezing conditions and different moulds used in these two studies as these parameters are 
known to affect the final porous structure [37]. Our findings are that in all cases the scaffolds 
demonstrated a highly porous structure with interconnected pores. 
Tissue engineering scaffolds need to have mechanical strength sufficient to withstand 
physiological in vivo forces and to maintain integrity until it is replaced by the newly formed 
tissue. The material itself plays an important role on the mechanical properties of the scaffold 
but the microstructure does as well. With this in mind there should be a good balance between 
pore size, porosity and mechanical properties, to facilitate cell infiltration, angiogenesis and 
mechanical stability [29].  Native soft tissues’ elastic behaviour is strongly influenced by ECM 
structural arrangement. For example soft tissues such as skin and aorta have UTS between 1-
20 MPa and 0.3-0.8 MPa respectively, and their εb is 30-70% and 50-100%, while tendon and 
ligaments exhibit UTS ranging 50-100 MPa and εb 10-15% [38, 39]. The PGSU scaffolds 
fabricated in this work were highly flexible and there was no yielding found before failure 
despite the high porosity. The UTS of the scaffolds (0.05 – 0.86 MPa) is comparable to aorta 
and the εb (91.42 – 122.6 %) is also sufficient to replicate the same elongation and flexibility. 
Furthermore, during the cyclic loading experiment, all scaffolds showed a negligible loss of 
mechanical strength after 100 cycles to 30% strain, indicating that these scaffolds can recover 
their mechanical strength after deformation making them suitable for flexible soft tissue 
applications where both strength and elasticity is required. This property is an advantage over 
some other polymeric scaffolds such as PLGA, PCL and PEG which were reported to undergo 
plastic deformation after tensile testing, making them non-ideal to be used in soft TE [10]. 
The polymer concentration had a more significant effect on the mechanical properties of 
the PGSU scaffolds in this study compared to the HDI content of the PGSU scaffolds 
fabricated by Frydrych and Chen [19]. In the previous work, it was found that by 
increasing the HDI content of the PGSU scaffolds the E decreased from 40 kPa to 30 kPa 
and the UTS increased 
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18 kPa to 22 kPa, while the εb increased from 49% to 82%  [19], which are all lower than the 
values reported in  this study owing to their different porosities and porous structures as well 
as chemical structures of the PGSU.  In another work of Frydrych et al. [21], PEU films were 
fabricated with multiple PEG molecular weights and it was found that the higher the 
molecular weight of PEG the higher the E, UTS and εb. A subsequent study regarding PEU 
by Wang et al. [22] investigated the effect of changing both the content of PEG and HDI and 
found that the highest UTS and E occurred when using the highest amount of HDI. 
Consequently, altering the reactants, polymer molecular weight and/or molar ratio of the 
reactants affects the mechanical properties of PGSU [18, 19] and PEU [21, 22] films, and in 
terms of PGSU scaffold, these parameters were less effective in changing its mechanical 
properties [19] when compared to varying the polymer concentration in the freeze-drying 
solution. 
Biomaterials usually are manipulated before transplantation therefore they should 
maintain their structure and mechanical integrity prior to transplantation [18].  When a 
scaffold is implanted in most cases it is sutured at the implantation site, thus the suture 
retention strength of the scaffold needs to be characterised. It was reported that the suture 
retention surgical requirement is 1.8 N (or 183 g, shown with dotted line Figure 2F) [33], 
and the PGSU-15% scaffold had a higher suture retention strength than the surgical 
requirement meaning that it can be securely sutured on the implantation site without 
structure failure.
The degradation mechanism of PGSU is based on surface erosion [18, 19]. Lipase 
can catalyse the hydrolysis of ester bonds, hence it is one of the most common enzymes used 
when examining the in vitro degradation characteristics of polyester materials [11, 
15, 40]. Degrading the PGSU samples in vitro with lipase shows a linear degradation rate 
dependent on the polymer concentration. The polymer concentration affects the degradation 
kinetics by influencing the surface area exposed to the enzyme, and since PGSU degrades 
by surface erosion, the degradation rate is decreased with increasing polymer 
concentration. Previous 
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work has shown that the surface to volume ratio has a significant effect on the degradation rate 
of the scaffold, which is in agreement with the results of this study [41]. The linear degradation 
observed from these scaffolds is also found from PGS scaffolds, and another property that they 
exhibit is PGS samples retain their mechanical properties while degrading, losing mechanical 
strength at a lower rate than mass loss [13, 16].
Pereira et al. examined PGSU films in vitro for their cell biocompatibility using MTT assay 
concluding no adverse effect on cell activity [18]. The in vitro cell biocompatibility results 
from this study showed the scaffolds supported cell adhesion and an increase in cell activity 
over time with no adverse effects. These results mean that the scaffolds provided a surface 
for the cells to adhere and proliferate. Many previous studies have shown that the cell 
metabolic activity is influenced significantly by pore size and porosity [29]. In this study, no 
changes in cell metabolic activity were observed when pore size and porosity were altered 
within the range studied. However, the cell penetration and cell distribution were affected 
(Figure 5). When the scaffolds were histologically analysed it was observed that the cells 
could penetrate less when the pore size was smaller. These findings are assumed to be due to 
the smaller pore size of the top surface of the scaffolds where cells were seeded, shown in 
Figure S4, Supplementary content. The PGSU-15% has a significantly smaller pore size (6.4 
μm) on the top surface compared to within the scaffold. These small pores were not sufficient 
to allow the cells to penetrate but provided a surface for them to attach, adhere and 
proliferate. The reason this smaller pore size surface is formed is because during pre-freezing 
stage the 1,4-dioxane freezes faster at the top surface resulting in smaller pores compared to 
the internal structure. If required, this top surface can be removed by slicing it off in further 
studies to enhance the cell penetration and distribution.
Natural ECM is largely composed of collagen; therefore, it is important to examine if the 
cells adhered to the scaffold produced collagen. The tissues we aim to replace are 
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predominantly collagen therefore as scaffold degrades new collagen should be produced to 
replace the scaffold’s structural support. Additionally, previous research studies have presented 
that newly produced collagen can increase or maintain the mechanical properties of the 
scaffold, thus the scaffold maintains its structure integrity allowing enough time for the new 
tissue to completely replace it [42, 43]. The PGSU-5% was characterised with a significantly 
higher collagen amount (7.5 ± 2.6% of dry sample weight) compared to the other two scaffolds, 
which can be explained with better cell penetration, distribution and higher surface area [44]. 
For comparison reasons, the collagen in cartilage accounts for 10-20% of the dry weight of 
cartilage, in tendon/ligaments 70-80%, aorta 25-35% and skin 60-80% [39, 45]. In this study 
we demonstrated that PGSU-5% encouraged collagen production reaching collagen amount 
close to cartilage tissue in 15 days static cell culture. Longer cell culture should be examined 
to determine if the collagen amount further increases over time.
There is evidence that pore size has a dramatic effect on cell mobility and differentiation, 
and this in turn may lead to a change to ingrowth of cells and blood vessels [23, 24]. Research 
into the optimum pore size for blood vessel ingrowth varies in the literature most probably 
because of different biomaterials used, however it was generally shown that the larger the pores 
the better the angiogenic properties. For example, one study of beta-tricalcium phosphate 
scaffolds with 150 µm pore size implanted into the bone defect of rabbit femoral condyles 
promoted angiogenesis most effectively when compared to 100 and 120 μm pore sizes [46]. 
Another study claimed PCL scaffolds with 300 µm pore size implanted into the omentum of Lewis 
rats had the optimal pore size compared to the cases with 80 and 160 μm pore sizes [47]; and 
another claims that PEG hydrogels with pores equal to 42 µm implanted between rat fascia and 
muscle allow significantly smaller vessel invasion compared to 82 μm and 135 μm [48]. 
In this work, we showed that the PGSU-5% scaffold had a higher angiogenic response when 
compared to the scaffold with a smaller pore size and lower porosity (PGSU-10%) (Figure 7), 
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in line with previous studies [35]. The PGSU-10% can be seen to increase the number of blood 
vessels growing towards the scaffold when implanted on the CAM assay, however this is not 
significantly different to the film and is not as pronounced as for the PGSU-5% scaffold. The 
pore size for the bottom surface that is in contact with the PGSU-10% is significantly lower as 
opposed to that of the PGSU-5% (11.0 ± 2.2 μm versus 26.5 ± 5.5 μm).
Histological analysis shows some degree of tissue ingrowth (Figure 8); however, for the 
PGSU-10%, the tissue is only able to penetrate the sides of the sample where the pores are 
slightly larger. For the larger pore size scaffold, PGSU-5% samples elicited dense, well 
integrated ingrowth that appears to show signs of blood vessel formation, as deep as 0.8 mm 
into the sample. The CAM is comprised of embryonic tissue which will have a higher 
regenerative and angiogenic capacity compared to an adult wound where these scaffolds may 
be used however the results are strongly encouraging. Of particular interest is that these results 
have been observed with no biochemical stimuli, such as vascular endothelial growth factor, 
fibroblast growth factor and endothelin. It is worth mentioning that a PGSU scaffold with a 
larger pore size (PGSU-2.5%, bottom surface pore size = 128.7 ± 15.3 μm, cross-section pore 
size = 96.2 ± 19.8 μm and porosity = 96.9 ± 0.7 %) has also been fabricated and examined for 
its angiogenic properties to determine if increasing pore size and porosity continues to have a 
positive effect on angiogenesis as in the cases reported in literature discussed before (Figure 
S6, Supplementary content). Briefly, it was found that there was a considerable level of tissue 
integration with approximately ~0.7 mm ingrowth; however, the tissue was less dense than the 
one grown into PGSU-5% leading to ineffectively filled pores, leaving large gaps where the 
tissue has appeared to have been unable to bridge the gaps between pore walls. Additionally, 
blood cells were leaking into the tissue, probably due to the poor development of vascular 
structures, caused by lack of structural support. Therefore, from this study it was found that for 
the PGSU scaffolds to have an adequate vascularisation and tissue ingrowth capabilities, their 
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microstructure features, namely pore size and porosity, should have an optimum range 
(exhibited from PGSU-5%) and altering these features has an adverse effect by either not 
providing structural support to the tissue integration (as in the case of PGSU-2.5%) or not 
porous enough (as in the case of PGSU-10%).
5. Conclusions
The findings of this study demonstrate the ability of large 3D PGSU scaffolds with appropriate 
porous structure and porosity to facilitate cell proliferation, high collagen production and a 
positive angiogenic response. The PGSU scaffolds exhibited elastomeric properties that could 
be stretched to almost double their initial length, demonstrated a negligible loss in mechanical 
strength after cyclic loading, suture retention strength close to the surgical requirement and 
linear enzymatic degradation, helping fill a gap in existing biomaterials for soft tissue 
engineering. Regarding the microstructure effect on the biological response of the scaffolds, it 
was found that the smaller pore size of the highest concentration scaffolds negatively affected 
the cell penetration and consequently reduced the collagen production. While the scaffold 
degrades it is important to allow its replacement by newly formed tissue and blood vessels to 
support the viability of the tissue. In this study, it was found that the PGSU-5% scaffolds with 
medium range pore size (~26 ฀ 28 μm) and high porosity (96 %) promoted tissue and blood 
vessel ingrowth, without the need for additional biochemical stimuli. It is therefore considered 
that PGSU scaffolds have potential to be further tuned and used in the engineering of soft 
tissues where flexibility and mechanical strength are required and are in dynamic in vivo 
environments such as skin, oral mucosa, blood vessels and ligaments.
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Poly(glycerol sebacate urethane) (PGSU) macroscopic sample
Figure S1: Macroscopic image of PGSU-5% scaffold.
Sol content
The sol content of the PGSU scaffolds (n = 5, sample size: 20 x 5 x 10 mm3) was measured 
by determining the mass difference before and after 24 h ethanol saturation at 21 °C. The 
mass loss decreased when the polymer concentration increased, which indicates that less 
unreacted monomers, oligomers and pre-polymers existed in the PGSU-15% scaffolds, and it 
was found to be statistically different to PGSU-5%.
Table S1: The residual analysis of the PGSU scaffolds after saturating the samples in ethanol for 24 hours. The mass loss of 
the samples is shown. The experiment was repeated n=5 and * when p < 0.05.
PGSU-5% PGSU-10% PGSU-15%
Mass loss 1.8 ± 0.2 %* 1.6 ± 0.1 % 1.5 ± 0.1 %*
Chemical Structure
Fourier transform spectroscopy (FT-IR) was performed using Perkin Elmer Spectrum one NTS 
analyser. Attenuated total reflection (ATR) was used at mid-infrared region of 4000-550 cm-1 
and recording resolution of 4 cm-1 at room temperature. The samples were collected from the 
centre and sides of the fabricated scaffolds. The number of scans was set to 20.
ATR-FTIR was carried out to confirm the synthesis and chemical structure of PGSU, with the 
spectra shown in Figure S2. The pre-PGS is characterised by the -OH stretch at 3450 cm-1, 
sharp peaks at 2929 cm-1 and 2856 cm-1 which belong to the stretch vibration of C-H, and 
finally carbonyl (C=O) and ether (C-O) stretching vibrations at 1732 cm-1 and 1160 cm-1, 
3
respectively [1]. The PGSU samples exhibit amine (-NH) stretch vibration at 3350 cm-1 and 
bending vibration of amide I, II and III bands at 1620 cm-1, 1578 cm-1 and 1238 cm-1, 
respectively, which are all absent in pre-PGS proving the formation of urethane linkage [2, 3]. 
Figure S2: ATR-FTIR spectra of pre-PGS and the PGSU scaffolds. All three polymer concentrations were examined and 
compared against pre-PGS that served as a control. FTIR was also carried out for the HDI. n=3.
The microstructure of PGSU scaffolds
From the SEM images in Figure S3 it was found that the scaffolds exhibited different pore 
sizes between their top surface, cross-section area and bottom surface. The measured pore sizes 
and porosities of the scaffolds are shown in Figure S4. The PGSU-5% and PGSU-10% had 
almost the same pore sizes at their top surface, 12.3 ± 1.9 μm and 12.3 ± 2.2 μm, respectively. 
However, the PGSU-15% scaffolds had a significantly smaller pore size equal to 6.4 ± 1.6 μm 
for its top surface. The cross-sectional area of all scaffolds had the same uniform pore structure, 
with elongated pores stacked on each other, but the pore size significantly decreased from 28.2 
± 5.3 μm to 16.1 ± 2.6 μm, as polymer concentration increased. The bottom section of the 
scaffolds had fewer pores when the polymer concentration was increased to the higher 
concentration, resulting in the PGSU-15% having an almost non-porous bottom surface, 
however, when there were pores they were larger than in the PGSU-10%. Pore size gradient 
was found for all three scaffolds. Less gradient was observed from PGSU-10% as there was 
not significant difference when comparing its top with bottom sections.
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Figure S3: SEM images of PGSU scaffolds (A1-6) PGSU-5%, (B1-6) PGSU-10% and (C1-6) PGSU-15%.
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Figure S4: Measured (A) pore size and (B) porosity of the PGSU scaffolds from three different sections. Results are shown as 
mean ± standard deviation, (A) n=50, *** when p < 0.001 between groups and ### when p < 0.001 within groups (colours are 
u   #   nguish the groups); (B) n=5, *** when p < 0.001.
Sirius red assay macroscopic images
The scaffolds were stained with Sirius red to quantify the collagen content. The red colour 
intensity is reduced with increasing polymer concentration, and negative control (acellular 
scaffolds) was assumed to be zero Sirius red stain. The PGSU-5% underwent some degree of 
contraction.
Figure S5: Images showing the scaffolds after picrosirius red staining, which stains collagen with red dye. A shrinkage is 
observed for the PGSU-5%, due to its weaker mechanical properties and higher collagen content. Negative control was 
acellular scaffold. Scale bar is 10 mm.
Microstructure and angiogenic properties of PGSU-2.5%
For comparison reasons, PGSU-2.5% scaffolds were fabricated to examine if increasing pore 
size and porosity will continue to have a positive response to the angiogenic properties of the 
scaffold. Below, Figure S6 shows the SEM images (A1, 2) of the PGSU-2.5% scaffold, the 
processed images with the surrounding vasculature (B1, 2), the histological images showing 
tissue ingrowth using H&E (C1, 2) and the pore sizes of the PGSU-2.5% scaffold. A uniform 
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circular microstructure was observed from the PGSU-2.5% scaffolds with pore sizes ranging 
from 45.2 ± 9.4 μm to 128.7 ± 15.3 μm. When implanted into the CAM considerable levels of 
tissue integration was evident, however large pore gaps where found and blood cells were 
leaking into the tissue, probably due to the poor development of vascular structures, caused by 
lack of structural support.
Figure S6: PGSU-2.5% fabricated and tested for angiogenesis for comparison reasons. The SEM images of PGSU-2.5% (A1) 
cross-section and (A2) bottom. Processed images of PGSU-2.5% showing the surrounding vasculature for (B1) day 7 and (B2) 
day 12 fertilisation. Histological images (C1, 2) of PGSU-2.5% and surrounding CAM fixed on day 13 and stained with H&E. 
(For D, results are shown mean ± standard deviation: n=50, *** when p < 0.001)
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